Recent advances in medicinal compounds related to corneal crosslinking
Frontiers in Pharmacology · 29.09.2023 · 14
DOI: 10.3389/fphar.2023.1232591 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 29.09.2023. Verfasst von Danyi Qin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Corneal crosslinking (CXL) is the recognized technique to strengthen corneal collagen fibers through photodynamic reaction, aiming to halt progressive and irregular changes in corneal shape. CXL has greatly changed the treatment for keratoconus (KCN) since it was introduced in the late 1990’s. Numerous improvements of CXL have been made during its developing course of more than 20 years. CXL involves quite a lot of materials, including crosslinking agents, enhancers, and supplements. A general summary of existing common crosslinking agents, enhancers, and supplements helps give a more comprehensive picture of CXL. Either innovative use of existing materials or research and development of new materials will further improve the safety, effectiveness, stability, and general applicability of CXL, and finally benefit the patients.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Eye Institute and Affiliated Xiamen Eye Center, School of Medicine, Xiamen University, Xiamen, Fujian, China.
Zitieren
APA
Qin, D., Han, Y., Wang, L., & Yin, H. (2023). Recent advances in medicinal compounds related to corneal crosslinking. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1232591
Vancouver
Qin D, Han Y, Wang L, Yin H. Recent advances in medicinal compounds related to corneal crosslinking. Frontiers in Pharmacology. 2023;14. doi:10.3389/fphar.2023.1232591
BibTeX
@article{Qin2023,
author = {Qin, Danyi and Han, Yi and Wang, Lixiang and Yin, Hongbo},
title = {Recent advances in medicinal compounds related to corneal crosslinking},
journal = {Frontiers in Pharmacology},
year = {2023},
volume = {14},
doi = {10.3389/fphar.2023.1232591}
}
EUVIMED